The Society for Surgical Oncology's Choosing Wisely guidelines recommend against sentinel lymph node biopsy (SLNB) in favor of observation in this population. Recent analyses reveal that this has not been… Click to show full abstract
The Society for Surgical Oncology's Choosing Wisely guidelines recommend against sentinel lymph node biopsy (SLNB) in favor of observation in this population. Recent analyses reveal that this has not been widely adopted. The purpose of this cost‐effectiveness analysis is to compare the costs and benefits associated with observation or SLNB in women >70 years old with hormone receptor–positive, clinically node‐negative, operable breast cancer.
               
Click one of the above tabs to view related content.